Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Dihlmann

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|October 9, 2004
Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeuticsSusanne Dihlmann, Magnus von Knebel Doeberitz
International Journal of Cancer|October 2, 2009
Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cellsGeorgios Patsos, Anja Germann, Johannes Gebert, et al.
Molecular Cancer Therapeutics|June 19, 2003
Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-cateninSusanne Dihlmann, Simone Klein, Magnus von Knebel Doeberitz Mv
Carcinogenesis|May 13, 2005
Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cellsSusanne Dihlmann, Matthias Kloor, Christine Fallsehr, et al.
Journal of Vascular Surgery|June 25, 2013
Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesisMaani Hakimi, Andreas Peters, Anja Becker, et al.
Oxidative Medicine and Cellular Longevity|February 6, 2023
Mitochondrial Dysfunction and Increased DNA Damage in Vascular Smooth Muscle Cells of Abdominal Aortic Aneurysm (AAA-SMC)Bengi S Tavris, Andreas S Peters, Dittmar Böckler, et al.
Molecular Medicine (Cambridge, Mass.)|September 16, 2020
Deficiency in Aim2 affects viability and calcification of vascular smooth muscle cells from murine aortas and angiotensin-II induced aortic aneurysmsMarkus Wortmann, Muhammad Arshad, Maani Hakimi, et al.
Biochemical Society Transactions|March 21, 2014
Glyoxalase I (Glo1) and its metabolites in vascular diseaseMarkus Wortmann, Andreas S Peters, Maani Hakimi, et al.
Immunity & Ageing : I & A|October 9, 2015
Gene expression of inflammasome components in peripheral blood mononuclear cells (PBMC) of vascular patients increases with ageXiaoyu Wu, Maani Hakimi, Markus Wortmann, et al.
International Journal of Cancer|June 12, 2003
Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirinAnja Germann, Susanne Dihlmann, Manfred Hergenhahn, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|October 9, 2004
Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeuticsSusanne Dihlmann, Magnus von Knebel Doeberitz
International Journal of Cancer|October 2, 2009
Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cellsGeorgios Patsos, Anja Germann, Johannes Gebert, et al.
Molecular Cancer Therapeutics|June 19, 2003
Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-cateninSusanne Dihlmann, Simone Klein, Magnus von Knebel Doeberitz Mv
Carcinogenesis|May 13, 2005
Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cellsSusanne Dihlmann, Matthias Kloor, Christine Fallsehr, et al.
Journal of Vascular Surgery|June 25, 2013
Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesisMaani Hakimi, Andreas Peters, Anja Becker, et al.
Oxidative Medicine and Cellular Longevity|February 6, 2023
Mitochondrial Dysfunction and Increased DNA Damage in Vascular Smooth Muscle Cells of Abdominal Aortic Aneurysm (AAA-SMC)Bengi S Tavris, Andreas S Peters, Dittmar Böckler, et al.
Molecular Medicine (Cambridge, Mass.)|September 16, 2020
Deficiency in Aim2 affects viability and calcification of vascular smooth muscle cells from murine aortas and angiotensin-II induced aortic aneurysmsMarkus Wortmann, Muhammad Arshad, Maani Hakimi, et al.
Biochemical Society Transactions|March 21, 2014
Glyoxalase I (Glo1) and its metabolites in vascular diseaseMarkus Wortmann, Andreas S Peters, Maani Hakimi, et al.
Immunity & Ageing : I & A|October 9, 2015
Gene expression of inflammasome components in peripheral blood mononuclear cells (PBMC) of vascular patients increases with ageXiaoyu Wu, Maani Hakimi, Markus Wortmann, et al.
International Journal of Cancer|June 12, 2003
Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirinAnja Germann, Susanne Dihlmann, Manfred Hergenhahn, et al.
Pageof 4